drugset / Trial / NCT00746811
Effects of Prescription Omega-3 on LDL-C in Primary Hypercholesterolemia
RandomizedCrossoverDouble-blindTreatment
Summary
The objectives of this study are to assess the effects of 4 g/d P-OM3, compared with placebo, on LDL-C and other aspects of the fasting lipid profile in subjects with primary hypercholesterolemia.
Timeline
- Start
- 2010-01
- Primary completion
- 2010-07
- Completion
- 2010-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lovaza | Other / unclassified | 4 g | — |